{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:46:00Z","timestamp":1791895560549,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11030-023-10676-w","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T03:22:06Z","timestamp":1688786526000},"page":"1577-1596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Novel fluoroquinolones analogues bearing 4-(arylcarbamoyl)benzyl: design, synthesis, and antibacterial evaluation"],"prefix":"10.1007","volume":"28","author":[{"given":"Fariba","family":"Peytam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Norouzbahari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toktam","family":"Saadattalab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"\u015eanl\u0131t\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loghman","family":"Firoozpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Emamgholipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab Ghasemi","family":"Dogaheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Nikou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliheh Barazandeh","family":"Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Bijanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcmtaz","family":"G\u00fcran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4037-9436","authenticated-orcid":false,"given":"Alireza","family":"Foroumadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,8]]},"reference":[{"key":"10676_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1001\/jama.281.1.61","volume":"281","author":"GL Armstrong","year":"1999","unstructured":"Armstrong GL, Conn LA, Pinner RW (1999) Trends in infectious disease mortality in the United States during the 20th century. Jama 281:61\u201366. https:\/\/doi.org\/10.1001\/jama.281.1.61","journal-title":"Jama"},{"key":"10676_CR2","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1056\/nejme058023","volume":"352","author":"HF Chambers","year":"2005","unstructured":"Chambers HF (2005) Community-associated MRSA\u2014resistance and virulence converge. N Engl Med 352:1485\u20131487. https:\/\/doi.org\/10.1056\/nejme058023","journal-title":"N Engl Med"},{"key":"10676_CR3","doi-asserted-by":"publisher","first-page":"104176","DOI":"10.1016\/j.bioorg.2020.104176","volume":"103","author":"R Song","year":"2020","unstructured":"Song R, Wang Y, Wang M, Gao R, Yang T, Yang S, Yang C-G, Jin Y, Zou S, Cai J (2020) Design and synthesis of novel desfluoroquinolone-aminopyrimidine hybrids as potent anti-MRSA agents with low hERG activity. Bioorg Chem 103:104176. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104176","journal-title":"Bioorg Chem"},{"key":"10676_CR4","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.annemergmed.2007.07.004","volume":"355","author":"GJ Moran","year":"2006","unstructured":"Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA (2006) Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355:666\u2013674. https:\/\/doi.org\/10.1016\/j.annemergmed.2007.07.004","journal-title":"N Engl J Med"},{"key":"10676_CR5","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3201\/eid1106.040641","volume":"11","author":"GJ Moran","year":"2005","unstructured":"Moran GJ, Amii RN, Abrahamian FM, Talan DA (2005) Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 11:928. https:\/\/doi.org\/10.3201\/eid1106.040641","journal-title":"Emerg Infect Dis"},{"key":"10676_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/jac\/dkg104","volume":"51","author":"P Wilson","year":"2003","unstructured":"Wilson P, Andrews J, Charlesworth R, Walesby R, Singer M, Farrell D, Robbins M (2003) Linezolid resistance in clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 51:186\u2013188. https:\/\/doi.org\/10.1093\/jac\/dkg104","journal-title":"J Antimicrob Chemother"},{"key":"10676_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.annemergmed.2004.10.011","volume":"45","author":"BW Frazee","year":"2005","unstructured":"Frazee BW, Lynn J, Charlebois ED, Lambert L, Lowery D, Perdreau-Remington F (2005) High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 45:311\u2013320. https:\/\/doi.org\/10.1016\/j.annemergmed.2004.10.011","journal-title":"Ann Emerg Med"},{"key":"10676_CR8","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1097\/01.aog.0000170861.29348.64","volume":"352","author":"SK Fridkin","year":"2005","unstructured":"Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM (2005) Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352:1436\u20131444. https:\/\/doi.org\/10.1097\/01.aog.0000170861.29348.64","journal-title":"N Engl J Med"},{"key":"10676_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0167-4781(98)00127-4","volume":"1400","author":"DC Hooper","year":"1998","unstructured":"Hooper DC (1998) Clinical applications of quinolones. Biochim Biophys Acta BBA 1400:45\u201361. https:\/\/doi.org\/10.1016\/S0167-4781(98)00127-4","journal-title":"Biochim Biophys Acta BBA"},{"key":"10676_CR10","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/S0025-7125(05)70297-2","volume":"84","author":"RC Owens Jr","year":"2000","unstructured":"Owens RC Jr, Ambrose PG (2000) Clinical use of the fluoroquinolones. Med Clin N Am 84:1447\u20131469. https:\/\/doi.org\/10.1016\/S0025-7125(05)70297-2","journal-title":"Med Clin N Am"},{"key":"10676_CR11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2174\/156802609789630947","volume":"9","author":"K Drlica","year":"2009","unstructured":"Drlica K, Hiasa H, Kerns R, Malik M, Mustaev A, Zhao X (2009) Quinolones: action and resistance updated. Curr Top Med Chem 9:981\u2013998. https:\/\/doi.org\/10.2174\/156802609789630947","journal-title":"Curr Top Med Chem"},{"key":"10676_CR12","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/bi5000564","volume":"53","author":"KJ Aldred","year":"2014","unstructured":"Aldred KJ, Kerns RJ, Osheroff N (2014) Mechanism of quinolone action and resistance. Biochemistry 53:1565\u20131574. https:\/\/doi.org\/10.1021\/bi5000564","journal-title":"Biochemistry"},{"key":"10676_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/s1359-6446(01)01760-3","volume":"6","author":"TJ Dougherty","year":"2001","unstructured":"Dougherty TJ, Beaulieu D, Barrett JF (2001) New quinolones and the impact on resistance. Drug Discov Today 6:529\u2013536. https:\/\/doi.org\/10.1016\/s1359-6446(01)01760-3","journal-title":"Drug Discov Today"},{"key":"10676_CR14","doi-asserted-by":"publisher","first-page":"8665","DOI":"10.1093\/nar\/gkr556","volume":"39","author":"Y Timsit","year":"2011","unstructured":"Timsit Y (2011) Local sensing of global DNA topology: from crossover geometry to type II topoisomerase processivity. Nucleic Acids Res 39:8665\u20138676. https:\/\/doi.org\/10.1093\/nar\/gkr556","journal-title":"Nucleic Acids Res"},{"key":"10676_CR15","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ejmech.2017.11.082","volume":"143","author":"G-F Zhang","year":"2018","unstructured":"Zhang G-F, Zhang S, Pan B, Liu X, Feng L-S (2018) 4-Quinolone derivatives and their activities against Gram positive pathogens. Eur J Med Chem 143:710\u2013723. https:\/\/doi.org\/10.1016\/j.ejmech.2017.11.082","journal-title":"Eur J Med Chem"},{"key":"10676_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/jac\/33.4.685","volume":"33","author":"JM Domagala","year":"1994","unstructured":"Domagala JM (1994) Structure-activity and structure-side-effect relationships for the quinolone antibacterials. J Antimicrob Chemother 33:685\u2013706. https:\/\/doi.org\/10.1093\/jac\/33.4.685","journal-title":"J Antimicrob Chemother"},{"key":"10676_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2174\/138955706776361493","volume":"6","author":"S Emami","year":"2006","unstructured":"Emami S, Shafiee A, Foroumadi A (2006) Structural features of new quinolones and relationship to antibacterial activity against Gram-positive bacteria. Mini Rev Med Chem 6:375\u2013386. https:\/\/doi.org\/10.2174\/138955706776361493","journal-title":"Mini Rev Med Chem"},{"key":"10676_CR18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","volume":"22","author":"LS Redgrave","year":"2014","unstructured":"Redgrave LS, Sutton SB, Webber MA, Piddock LJ (2014) Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol 22:438\u2013445. https:\/\/doi.org\/10.1016\/j.tim.2014.04.007","journal-title":"Trends Microbiol"},{"key":"10676_CR19","doi-asserted-by":"publisher","first-page":"S180","DOI":"10.1086\/321846","volume":"33","author":"LR Peterson","year":"2001","unstructured":"Peterson LR (2001) Quinolone molecular structure-activity relationships: what we have learned about improving antimicrobial activity. Clin Infect Dis 33:S180\u2013S186. https:\/\/doi.org\/10.1086\/321846","journal-title":"Clin Infect Dis"},{"key":"10676_CR20","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/chin.200748152","volume":"55","author":"B Letafat","year":"2007","unstructured":"Letafat B, Emami S, Mohammadhosseini N, Faramarzi MA, Samadi N, Shafiee A, Foroumadi A (2007) Synthesis and antibacterial activity of new N-[2-(thiophen-3-yl) ethyl] piperazinyl quinolones. Chem Pharm Bull 55:894\u2013898. https:\/\/doi.org\/10.1002\/chin.200748152","journal-title":"Chem Pharm Bull"},{"key":"10676_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ardp.200700090","volume":"341","author":"S Emami","year":"2008","unstructured":"Emami S, Foroumadi A, Faramarzi MA, Samadi N (2008) Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety. Arch Pharm 341:42\u201348. https:\/\/doi.org\/10.1002\/ardp.200700090","journal-title":"Arch Pharm"},{"key":"10676_CR22","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1016\/j.ejmech.2011.04.035","volume":"46","author":"R Kumar","year":"2011","unstructured":"Kumar R, Kumar A, Jain S, Kaushik D (2011) Synthesis, antibacterial evaluation and QSAR studies of 7-[4-(5-aryl-1, 3, 4-oxadiazole-2-yl) piperazinyl] quinolone derivatives. Eur J Med Chem 46:3543\u20133550. https:\/\/doi.org\/10.1016\/j.ejmech.2011.04.035","journal-title":"Eur J Med Chem"},{"key":"10676_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejmech.2013.07.032","volume":"68","author":"S Emami","year":"2013","unstructured":"Emami S, Ghafouri E, Faramarzi MA, Samadi N, Irannejad H, Foroumadi A (2013) Mannich bases of 7-piperazinylquinolones and kojic acid derivatives: synthesis, in vitro antibacterial activity and in silico study. Eur J Med Chem 68:185\u2013191. https:\/\/doi.org\/10.1016\/j.ejmech.2013.07.032","journal-title":"Eur J Med Chem"},{"key":"10676_CR24","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.arabjc.2011.04.008","volume":"8","author":"PC Sharma","year":"2015","unstructured":"Sharma PC, Jain A, Yar MS, Pahwa R, Singh J, Goel S (2015) Synthesis and antibacterial evaluation of novel analogs of fluoroquinolones annulated with 6-substituted-2-aminobenzothiazoles. Arab J Chem 8:671\u2013677. https:\/\/doi.org\/10.1016\/j.arabjc.2011.04.008","journal-title":"Arab J Chem"},{"key":"10676_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11030-017-9795-y","volume":"22","author":"K Dileep","year":"2018","unstructured":"Dileep K, Polepalli S, Jain N, Buddana SK, Prakasham R, Murty M (2018) Synthesis of novel tetrazole containing hybrid ciprofloxacin and pipemidic acid analogues and preliminary biological evaluation of their antibacterial and antiproliferative activity. Mol Diversity 22:83\u201393. https:\/\/doi.org\/10.1007\/s11030-017-9795-y","journal-title":"Mol Diversity"},{"key":"10676_CR26","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s11030-018-9907-3","volume":"23","author":"E Soleimani","year":"2019","unstructured":"Soleimani E, Torkaman S, Sepahvand H, Ghorbani S (2019) Ciprofloxacin-functionalized magnetic silica nanoparticles: as a reusable catalyst for the synthesis of 1 H-chromeno [2, 3-d] pyrimidine-5-carboxamides and imidazo [1, 2-a] pyridines. Mol Diversity 23:739\u2013749. https:\/\/doi.org\/10.1007\/s11030-018-9907-3","journal-title":"Mol Diversity"},{"key":"10676_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/cbdd.13638","volume":"95","author":"IA Seliem","year":"2020","unstructured":"Seliem IA, Panda SS, Girgis AS, Nagy YI, George RF, Fayad W, Fawzy NG, Ibrahim TS, Al-Mahmoudy AM, Sakhuja R (2020) Design, synthesis, antimicrobial, and DNA gyrase inhibitory properties of fluoroquinolone\u2013dichloroacetic acid hybrids. Chem Biol Drug Design 95:248\u2013259. https:\/\/doi.org\/10.1111\/cbdd.13638","journal-title":"Chem Biol Drug Design"},{"key":"10676_CR28","doi-asserted-by":"publisher","first-page":"133007","DOI":"10.1016\/j.molstruc.2022.133007","volume":"1262","author":"P Yang","year":"2022","unstructured":"Yang P, Luo J-B, Wang Z-Z, Zhang L-L, Xie X-B, Shi Q-S, Zhang X-G (2022) Synthesis and in vitro antibacterial activity of N-acylarylhydrazone-ciprofloxacin hybrids as novel fluoroquinolone derivatives. J Mol Struct 1262:133007. https:\/\/doi.org\/10.1016\/j.molstruc.2022.133007","journal-title":"J Mol Struct"},{"key":"10676_CR29","doi-asserted-by":"publisher","first-page":"128885","DOI":"10.1016\/j.bmcl.2022.128885","volume":"73","author":"Y-M Tan","year":"2022","unstructured":"Tan Y-M, Li D, Li F-F, Ansari MF, Fang B, Zhou C-H (2022) Pyrimidine-conjugated fluoroquinolones as new potential broad-spectrum antibacterial agents. Bioorg Med Chem Lett 73:128885. https:\/\/doi.org\/10.1016\/j.bmcl.2022.128885","journal-title":"Bioorg Med Chem Lett"},{"key":"10676_CR30","doi-asserted-by":"publisher","first-page":"114021","DOI":"10.1016\/j.ejmech.2021.114021","volume":"228","author":"NM Ibrahim","year":"2022","unstructured":"Ibrahim NM, Fahim SH, Hassan M, Farag AE, Georgey HH (2022) Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: potency and side effects. Eur J Med Chem 228:114021. https:\/\/doi.org\/10.1016\/j.ejmech.2021.114021","journal-title":"Eur J Med Chem"},{"key":"10676_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-022-10537-y","author":"N Kumar","year":"2022","unstructured":"Kumar N, Khanna A, Kaur K, Kaur H, Sharma A, Bedi PMS (2022) Quinoline derivatives volunteering against antimicrobial resistance: rational approaches, design strategies, structure activity relationship and mechanistic insights. Mol Diversity. https:\/\/doi.org\/10.1007\/s11030-022-10537-y","journal-title":"Mol Diversity"},{"key":"10676_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-022-10528-z","author":"HH Mohammed","year":"2022","unstructured":"Mohammed HH, Ali DME, Badr M, Habib AG, Mahmoud AM, Farhan SM, Gany SSHAE, Mohamad SA, Hayallah AM, Abbas SH (2022) Synthesis and molecular docking of new N 4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors. Mol Diversity. https:\/\/doi.org\/10.1007\/s11030-022-10528-z","journal-title":"Mol Diversity"},{"key":"10676_CR33","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s11030-021-10287-3","volume":"26","author":"TR Allaka","year":"2022","unstructured":"Allaka TR, Kummari B, Polkam N, Kuntala N, Chepuri K, Anireddy JS (2022) Novel heterocyclic 1, 3, 4-oxadiazole derivatives of fluoroquinolones as a potent antibacterial agent: synthesis and computational molecular modeling. Mol Diversity 26:1581\u20131596. https:\/\/doi.org\/10.1007\/s11030-021-10287-3","journal-title":"Mol Diversity"},{"key":"10676_CR34","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s11030-021-10302-7","volume":"26","author":"HA Aziz","year":"2022","unstructured":"Aziz HA, El-Saghier AM, Badr M, Abuo-Rahma GE-DA, Shoman ME (2022) Thiazolidine-2, 4-dione-linked ciprofloxacin derivatives with broad-spectrum antibacterial, MRSA and topoisomerase inhibitory activities. Mol Diversity 26:1743\u20131759. https:\/\/doi.org\/10.1007\/s11030-021-10302-7","journal-title":"Mol Diversity"},{"key":"10676_CR35","doi-asserted-by":"publisher","first-page":"134049","DOI":"10.1016\/j.molstruc.2022.134049","volume":"1271","author":"SA Abdel-Aziz","year":"2023","unstructured":"Abdel-Aziz SA, Cirnski K, Herrmann J, Abdel-Aal MA, Youssif BG, Salem OI (2023) Novel fluoroquinolone hybrids as dual DNA gyrase and urease inhibitors with potential antibacterial activity: design, synthesis, and biological evaluation. J Mol Struct 1271:134049. https:\/\/doi.org\/10.1016\/j.molstruc.2022.134049","journal-title":"J Mol Struct"},{"key":"10676_CR36","doi-asserted-by":"publisher","first-page":"134507","DOI":"10.1016\/j.molstruc.2022.134507","volume":"1274","author":"J Cardoso-Ortiz","year":"2023","unstructured":"Cardoso-Ortiz J, Leyva-Ramos S, Baines KM, G\u00f3mez-Dur\u00e1n CFA, Hern\u00e1ndez-L\u00f3pez H, Palacios-Can FJ, Valcarcel-Gami\u00f1o JA, Leyva-Peralta MA, Razo-Hern\u00e1ndez RS (2023) Novel ciprofloxacin and norfloxacin-tetrazole hybrids as potential antibacterial and antiviral agents: targeting S. aureus topoisomerase and SARS-CoV-2-MPro. J Mol Struct 1274:134507. https:\/\/doi.org\/10.1016\/j.molstruc.2022.134507","journal-title":"J Mol Struct"},{"key":"10676_CR37","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.3390\/molecules24213959","volume":"24","author":"G Marc","year":"2019","unstructured":"Marc G, Araniciu C, Oniga SD, Vlase L, P\u00eern\u0103u A, Nad\u0103\u0219 GC, Novac C\u0218, Matei IA, Chifiriuc MC, M\u0103ru\u021bescu L (2019) Design, synthesis and biological evaluation of new piperazin-4-yl-(acetyl-thiazolidine-2, 4-dione) norfloxacin analogues as antimicrobial agents. Molecules 24:3959. https:\/\/doi.org\/10.3390\/molecules24213959","journal-title":"Molecules"},{"key":"10676_CR38","doi-asserted-by":"publisher","first-page":"12300","DOI":"10.1074\/jbc.M113.529164","volume":"289","author":"A Mustaev","year":"2014","unstructured":"Mustaev A, Malik M, Zhao X, Kurepina N, Luan G, Oppegard LM, Hiasa H, Marks KR, Kerns RJ, Berger JM (2014) Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding. J Biol Chem 289:12300\u201312312. https:\/\/doi.org\/10.1074\/jbc.M113.529164","journal-title":"J Biol Chem"},{"key":"10676_CR39","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1128\/aac.33.10.1704","volume":"33","author":"K Akahane","year":"1989","unstructured":"Akahane K, Sekiguchi M, Une T, Osada Y (1989) Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites. Antimicrob Agents Chemother 33:1704\u20131708. https:\/\/doi.org\/10.1128\/aac.33.10.1704","journal-title":"Antimicrob Agents Chemother"},{"key":"10676_CR40","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ijantimicag.2014.01.004","volume":"43","author":"M Goswami","year":"2014","unstructured":"Goswami M, Mangoli S, Jawali N (2014) Importance of chemical modification at C-7 position of quinolones for glutathione-mediated reversal of antibacterial activity. Int J Antimicrob Agents 43:387\u2013388","journal-title":"Int J Antimicrob Agents"},{"key":"10676_CR41","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.ejmech.2008.09.012","volume":"44","author":"S Jazayeri","year":"2009","unstructured":"Jazayeri S, Moshafi MH, Firoozpour L, Emami S, Rajabalian S, Haddad M, Pahlavanzadeh F, Esnaashari M, Shafiee A, Foroumadi A (2009) Synthesis and antibacterial activity of nitroaryl thiadiazole\u2013gatifloxacin hybrids. Eur J Med Chem 44:1205\u20131209. https:\/\/doi.org\/10.1016\/j.ejmech.2008.09.012","journal-title":"Eur J Med Chem"},{"key":"10676_CR42","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s40199-020-00373-6","volume":"28","author":"M Norouzbahari","year":"2020","unstructured":"Norouzbahari M, Salarinejad S, G\u00fcran M, \u015eanl\u0131t\u00fcrk G, Emamgholipour Z, Bijanzadeh HR, Toolabi M, Foroumadi A (2020) Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety. DARU J Pharm Sci 28:661\u2013672. https:\/\/doi.org\/10.1007\/s40199-020-00373-6","journal-title":"DARU J Pharm Sci"},{"key":"10676_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpha.2015.11.005","volume":"6","author":"M Balouiri","year":"2016","unstructured":"Balouiri M, Sadiki M, Ibnsouda SK (2016) Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal 6:71\u201379. https:\/\/doi.org\/10.1016\/j.jpha.2015.11.005","journal-title":"J Pharm Anal"},{"key":"10676_CR44","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1248\/cpb.48.1964","volume":"48","author":"Y Okada","year":"2000","unstructured":"Okada Y, Tsuda Y, Tada M, Wanaka K, Okamoto U, Hijikata-Okunomiya A, Okamoto S (2000) Development of potent and selective plasmin and plasma kallikrein inhibitors and studies on the structure-activity relationship. Chem Pharm Bull 48:1964\u20131972. https:\/\/doi.org\/10.1248\/cpb.48.1964","journal-title":"Chem Pharm Bull"},{"key":"10676_CR45","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1021\/op700270n","volume":"12","author":"Y-F Liu","year":"2008","unstructured":"Liu Y-F, Wang C-L, Bai Y-J, Han N, Jiao J-P, Qi X-L (2008) A facile total synthesis of imatinib base and its analogues. Org Process Res Dev 12:490\u2013495. https:\/\/doi.org\/10.1021\/op700270n","journal-title":"Org Process Res Dev"},{"key":"10676_CR46","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1016\/j.ejmech.2007.09.022","volume":"43","author":"SA Khan","year":"2008","unstructured":"Khan SA, Saleem K, Khan Z (2008) Synthesis, structure elucidation and antibacterial evaluation of new steroidal-5-en-7-thiazoloquinoxaline derivatives. Eur J Med Chem 43:2257\u20132261. https:\/\/doi.org\/10.1016\/j.ejmech.2007.09.022","journal-title":"Eur J Med Chem"},{"key":"10676_CR47","doi-asserted-by":"publisher","first-page":"131084","DOI":"10.1016\/j.molstruc.2021.131084","volume":"1245","author":"O Temiz-Arpaci","year":"2021","unstructured":"Temiz-Arpaci O, Zeyrek CT, Arisoy M, Erol M, Celik I, Kaynak-Onurdag F (2021) Synthesis, quantum mechanical calculations, antimicrobial activities and molecular docking studies of five novel 2, 5-disubstituted benzoxazole derivatives. J Mol Struct 1245:131084. https:\/\/doi.org\/10.1016\/j.molstruc.2021.131084","journal-title":"J Mol Struct"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-023-10676-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-023-10676-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-023-10676-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T06:17:14Z","timestamp":1721801834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-023-10676-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,8]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10676"],"URL":"https:\/\/doi.org\/10.1007\/s11030-023-10676-w","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,8]]},"assertion":[{"value":"14 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study did not involve human subjects and\/or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}